I agree, I used to hold CXO, still hold LTR. if we haven’t...

I agree, I used to hold CXO, still hold LTR. if we haven’t started making some real SP moves by the first half of next year then I’ll be starting to question whether I’ve missed something when I looked at ESS.

I expect the scoping study and/or selection of offtake partners are most likely to be the catalyst for a rerate, both of which are next hear H1.